Theraplix is a

Europe Europe is a large peninsula conventionally considered a continent in its own right because of its great physical size and the weight of its history and traditions. Europe is also considered a subcontinent of Eurasia and it is located enti ...

pharmaceutical company The pharmaceutical industry discovers, develops, produces, and markets drugs or pharmaceutical drugs for use as medications to be administered to patients (or self-administered), with the aim to cure them, vaccinate them, or alleviate sympt ...

. Founded in 1931 by the pharmacist

François Albert-Buisson François Albert-Buisson (; 3 May 1881, Issoire, Puy-de-Dôme – 21 May 1961, Aix-en-Provence) was a French entrepreneur, industrial, consular magistrate, economist, politician, historian. Background François Albert-Buisson was born in 1881 t ...

, It is now a subsidiary of

Sanofi Sanofi S.A. is a French Multinational corporation, multinational pharmaceutical and healthcare company headquartered in Paris, France. Originally, the corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synth� ...

. One of their products is the

antipsychotic Antipsychotics, also known as neuroleptics, are a class of psychotropic medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia but also in a range o ...

cyamemazine Cyamemazine (Tercian), also known as cyamepromazine, is a typical antipsychotic drug of the phenothiazine class which was introduced by Theraplix in France in 1972 and later in Portugal as well. Medical use It is used for the treatment of schizo ...

(Tercian). Their products include: Amidezel, Diamex, Hexomedine Solution, Cathomycine, Kanamylone, Theraleneand Trecator. In the 1960s they distributed gifts to physicians in the form of collage cards. They were mostly of Asian subjects and were suitable for framing.

References

Pharmaceutical companies of France Companies based in Paris Sanofi {{Pharmacology-stub